Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ellen J Schlette
mTOR Signaling Is Activated by FLT3 Kinase and Promotes Survival of FLT3-mutated Acute Myeloid Leukemia Cells
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
Related publications
Targeting BTK for the Treatment of FLT3-ITD Mutated Acute Myeloid Leukemia
Scientific Reports
Multidisciplinary
Tyrosine Kinase Inhibition Increases the Cell Surface Localization of FLT3-ITD and Enhances FLT3-directed Immunotherapy of Acute Myeloid Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
FLT3-TKD Mutation in Childhood Acute Myeloid Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
FLT3 Inhibitors in the Treatment of Acute Myeloid Leukemia
Cancer
Cancer Research
Oncology
Differential Signaling of Flt3 Activating Mutations in Acute Myeloid Leukemia: A Working Model
Protein & Cell
Biochemistry
Biotechnology
Drug Discovery
Cell Biology
Medicine
Inhibition of FLT3 Expression by Green Tea Catechins in FLT3 Mutated-Aml Cells
PLoS ONE
Multidisciplinary
8-Chloro-Adenosine Activity in FLT3-ITD Acute Myeloid Leukemia
Journal of Cellular Physiology
Clinical Biochemistry
Cell Biology
Physiology
Concurrent Inhibition of Pim and FLT3 Kinases Enhances Apoptosis of FLT3-ITD Acute Myeloid Leukemia Cells Through Increased McL-1 Proteasomal Degradation
Clinical Cancer Research
Cancer Research
Oncology
The Evolving Role of FLT3 Inhibitors in Acute Myeloid Leukemia: Quizartinib and Beyond
Therapeutic Advances in Hematology
Hematology
